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DObjectives: The objective of this study was to evaluate the effect of chronic preoperative hemodialysis for end-
stage renal failure in patients undergoing valve surgery.
Methods: A retrospective review of patients undergoing primary valve with or without coronary artery bypass
surgery from 1996 to 2008 at a US academic center was performed. The patients were divided into two groups:
group 1 underwent valve surgery without preoperative dialysis (n¼ 5084) and group 2 underwent valve surgery
with preoperative dialysis (n ¼ 224). The outcomes were evaluated using multivariate regression analysis, and
long-term survival was assessed with Kaplan-Meier plots.
Results:The patients in group 2 were younger (P<.001), were more likely women (P¼ .04), and presented with
New York Heart Association class III-IV (P<.001). The ejection fraction was similar between the two groups
(P ¼ .36). The adjusted perioperative morbidity was similar between the two groups for stroke (P ¼ .79) and
myocardial infarction (P ¼ .68). Resource use (postoperative length of stay) was greater in group 2
(P<.001), as was in-hospital mortality (group 1, 263/5084 [5.2%] vs group 2, 41/224 [18.3%]; P<.001).
The 1-, 5-, and 10-year survival was less in group 2 (P<.001); the median survival was 12 or more years in
group 1 and 1.8 years in group 2. Preoperative end-state renal disease, among others, show a trend as an inde-
pendent predictor for short-term mortality and was a significant predictor for long-term mortality.
Conclusions: In this large cohort of patients, preoperative dialysis conferred a high risk of perioperative mor-
bidity and mortality and poor long-term survival after valve surgery. Risk stratification and future research ef-
forts should focus on more precise identification of the benefits of valve surgery in this high-risk patient
population. (J Thorac Cardiovasc Surg 2012;144:117-23)The prevalence of end-stage renal disease (ESRD) con-
tinues to increase in the United States. The 2009 annual
data report from the United States Renal Data System re-
vealed that as of 2007, 527,282 patients had ESRD in the
United States.1 The projections from this report estimate
that the prevalence of ESRD in the United States will ap-
proach 775,000 by 2020. This steady increase in patients
with ESRD parallels similar trends seen around the
world.2,3 Furthermore, the United States Renal Data
System data report revealed that the prevalence rates are
increasing most rapidly among patients aged 65 years and
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The Journal of Thoracic and CaCardiovascular disease and its complications are the most
common cause of death among patients with ESRD, espe-
cially among the older age groups. The multiple shared
risk factors that lead to the development of cardiovascular
and renal disease cause the two disease processes to often
exist and progress in concert with one another.4,5 Once
patients have developed ESRD and dialysis dependence,
they have often already developed significant symptoms
related to coronary artery disease, heart failure, and valve-
related cardiac abnormalities.6
Although multiple studies have examined the outcomes
in patients with ESRD undergoing cardiac surgery, many
of these studies examined the outcomes after all types of
cardiac surgery and did not focus solely on the outcomes af-
ter valve-related procedures.3,7-16 Therefore, the purpose of
the present study was to investigate the short- and long-term
outcomes in patients requiring preoperative dialysis and un-
dergoing cardiac valve surgery.METHODS
The present retrospective, cohort study sought to determine the effect of
a preoperative diagnosis of renal failure requiring dialysis on the clinical
outcomes after cardiac valve surgery. The patients were classified into
two groups—those requiring dialysis preoperatively and those who did
not. The patients were identified by querying the institutional Society of
Thoracic Surgeons (STS) Adult Cardiac Database for consecutive qualifiedrdiovascular Surgery c Volume 144, Number 1 117
TABLE 1. Preoperative demographics and clinical characteristics by
dialysis status
Characteristic
No preoperative
dialysis
(n ¼ 5084)
Preoperative
dialysis
(n ¼ 224) P value
Age (y) <.001
Mean  SD 61.2  14.8 54.1  14.0
Median 63 55
Female gender (n) 2172 (42.7) 111 (49.6) 0.043
Status (n) <.001
Elective 4017 (79.0) 143 (63.8)
Urgent 849 (16.7) 64 (28.6)
Emergent 216 (4.3) 17 (7.6)
White race (n) 3523 (80.1) 58 (31.5) <.001
Hypertension (n) 3264 (64.2) 213 (95.1) <.001
Ejection fraction (n) .36
Mean  SD 52.8  13.1 53.7  13.3
Median 55 55
NYHA class III or IV (n) 683 (19.4) 56 (31.5) <.001
Previous stroke 370 (7.3) 48 (21.4) <.001
Chronic lung disease .40
None 2623 (81.5) 137 (83.5)
Mild 379 (11.8) 13 (7.9)
Moderate 85 (2.6) 6 (3.7)
Severe 130 (4.0) 8 (4.9)
Diabetes 933 (18.45) 87 (38.8) <.001
Chronic lung disease 594 (11.7) 27 (12.1) .87
Previous myocardial infarction 798 (15.7) 46 (20.5) .053
Cerebrovascular disease 647 (12.7) 53 (23.7) <.001
Peripheral vascular disease 301 (5.9) 42 (18.8) <.001
Preoperative serum creatinine <.001
Mean  SD 1.14  0.61 7.34  3.17
Median 1.00 7.05
Chronic renal insufficiency 305 (6.0) 224 (100.0) <.001
Infectious endocarditis 327 (6.4) 78 (34.8) <.001
Current smoker 1756 (34.5) 83 (37.1) .44
Preoperative IABP 42 (0.8) 2 (0.9) .91
Immunosuppressive therapy 250 (4.9) 33 (14.7) <.001
STS predicted risk of
mortality (%)
<.001
Mean  SD 4.1  4.2 14.8  9.2
Median 2.8 13.0
Data in parentheses are percentages. SD, Standard deviation; NYHA, New York Heart
Association; IABP, Intra-aortic balloon counterpulsation; STS, Society of Thoracic
Surgeons.
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
ESRD ¼ end-stage renal disease
STS ¼ Society of Thoracic Surgeons
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Dpatients treated at Emory University Healthcare Hospitals from January 1,
1996 to December 31, 2008. Patients with concomitant coronary artery by-
pass grafting (CABG)were included and thosewith previous valve surgery,
those with previous CABG, and those undergoing salvage treatment were
excluded.
During this period, 5308 qualified patients underwent valve surgery. Of
these, 224 patients (4.2%) were receiving preoperative dialysis. Of the
5084 patients not receiving dialysis, 305 patients (6.0%) were diagnosed
with nondialysis-dependent chronic renal failure and were categorized in
the ‘‘no preoperative dialysis’’ group. The extracted records included the
demographic data, pre-existing conditions, and clinical outcomes. The
study was formally approved by the Emory University institutional review
board in compliance with Health Insurance Portability and Accountability
Act regulations and the Declaration of Helsinki. The institutional review
board waived individual patient consent for these patients.
Interventions, Surgeons, and Surgical Technique
Each patient underwent a single surgical session performed at the dis-
cretion of any of 20 faculty surgeons. Cardiac catheterization was per-
formed in all patients older than 40 years or in younger patients with risk
factors for coronary artery disease. The nephrology service was consulted
before surgical intervention and treated the patients for renal replacement
and electrolyte management in all patients requiring preoperative dialysis.
Standard cardiopulmonary bypass (CPB) techniques for valve operations
were used in all patients. The surgical approach, valve prosthesis or repair
techniques, and conduct of CPB and myocardial protection were left to the
discretion of the attending cardiac surgeon. Typically, conventional CPB
was performed using roller head pumps, membrane oxygenators, cardiot-
omy suction, arterial filters, cold antegrade and retrograde blood cardiople-
gia, and moderate systemic hypothermia (32 to 34C). The operative field
was routinely flooded with carbon dioxide, and de-airing maneuvers were
performed in all cases before releasing the cross-clamp. In those requiring
preoperative dialysis, postoperative extubation was generally performed
after dialysis.
Long-Term Follow-up
The Social Security Death Index is a public, national database of death
records extracted from the United States Social Security Administration’s
Death Master File Extract. Patients with a Social Security number who
have died after 1963 and whose death has been reported to the Social Se-
curity Administration will be listed in the Social Security Death Index.
For all patients who died before the cutoff date of June 30, 2008, a mortality
date was provided, allowing creation of Kaplan-Meier long-term survival
curves. The cause of death was not available for any of the patients;
thus, the present study described all-cause long-term mortality.
Variables of Interest
Before analysis, 19 preoperative risk factors were harvested from
the STS database (Table 1). Standard STS definitions for each risk fac-
tor and outcome were used. Race was dichotomized as either white or
nonwhite. Chronic lung disease (chronic obstructive pulmonary dis-
ease) was ordinally measured in some latter years and dichotomously118 The Journal of Thoracic and Cardiovascular Surgmeasured in earlier years; in the present study, it was dichotomized.
The new York Hospital Association heart failure classification was di-
chotomized as class III-IV or I-II. The primary outcomes examined in
the present study were in-hospital mortality and long-term survival;
other endpoints of interest included permanent stroke (cerebrovascular
accident), myocardial infarction, the composite endpoint for any of
these major adverse cardiac and cerebrovascular events, and operative
re-intervention.
Data Management and Statistical Analysis
All data for the consecutive patients were entered into a computerized
surgical database, using the fields and definitions of the STSNational Adult
Cardiac Database. Checks for data quality were used at both theery c July 2012
TABLE 2. Operative characteristics by dialysis status
Operative data
No preoperative
dialysis
(n ¼ 5084)
Preoperative
dialysis
(n ¼ 224) P value
Isolated aortic valve
replacement
1446 (28.4) 64 (28.6) .97
Isolated mitral valve repair or
replacement
1149 (22.6) 38 (17.0) .048
Any valve plus concomitant
CABG
1672 (32.9) 65 (29.0) .23
Other isolated valve or combo
valves
817 (16.1) 57 (25.5) <.001
Bioprosthetic valve 2500 (49.2) 128 (57.1) .02
Body mass index (kg/m2) .057
Mean  SD 27.8  5.9 26.9  6.7
Median 26.9 25.8
Aortic cross-clamp time (min) <.001
Mean  SD 93.5  38.0 104.6  40.4
Median 86.0 98.0
Cardiopulmonary bypass
time (min)
<.001
Mean  SD 131.3  49.3 144.2  50.7
Median 121 137
Intraoperative IABP
implanted
258 (5.1) 13 (4.8) .63
Data presented as numbers (%), unless otherwise noted. CABG, Coronary artery
Thourani et al Acquired Cardiovascular Disease
A
C
Dinstitutional level and before final entry into the STS National Adult Car-
diac Database.
To statistically evaluate the effects of preoperative dialysis on in-
hospital mortality, amultivariate logistic regressionmodelwas constructed.
The model contained preoperative covariates to adjust for potential selec-
tion bias; age, gender, body mass index, renal failure, heart failure, ejection
fraction, presence of concomitant CABG, infectious endocarditis, previous
stroke, diabetes mellitus, and chronic lung disease. Adjusted odds ratios as-
sociated with preoperative dialysis and other covariates, along with the
95% confidence intervals (CIs), were computed.
Long-term survival comparisons were made using adjusted Cox propor-
tional hazards regression (PHREG) models and Kaplan-Meier product-
limit estimates (unadjusted). Kaplan-Meier curves were generated that
provide survival estimates at postoperative points. Differences between
dialysis status were determined using log-rank tests. These estimates in-
cluded operative deaths.
Adjusted long-term survival comparisons were made using PHREG to
model the instantaneous hazard of death as a function of dialysis, adjusted
for age, gender, body mass index, renal failure, heart failure, ejection frac-
tion, presence of concomitant CABG, infectious endocarditis, previous
stroke, diabetes mellitus, and chronic lung disease. The proportional haz-
ards assumption was verified using a correlation analysis of the Schoenfeld
residuals and ranked follow-up time. Adjusted hazard ratios were generated
for each model term, along with the 95% CIs.
The data were managed and analyzed using SAS, version 9.1 (SAS In-
stitute, Cary, NC). Unadjusted comparisons were performed using chi-
square tests and two-sample t tests for categorical and numerical predictors,
respectively. All statistical tests were two-sided using an a ¼ 0.05 level of
significance.bypass grafting; SD, Standard deviation; IABP, Intra-aortic balloon counterpulsa-
tion.RESULTS
Preoperative and Operative Characteristics
A total of 5308 patients underwent valve surgery at a sin-
gle academic institution and constituted the study group.
The patients were divided into two groups: group 1 received
no preoperative dialysis (n ¼ 5084) and group 2 received
preoperative dialysis (n¼ 224). The preoperative character-
istics are listed in Table 1. Despite being younger and with
equally preserved ejection fractions, patients requiring pre-
operative dialysis were uniformly sicker preoperatively
compared with the nondialysis patients. This was evident
in the STS Predicted Risk of In-hospital Mortality of
4.1% versus 14.8% (P<.001).
Table 2 describes the operative procedures according to
the need for preoperative chronic dialysis. In both groups,
the most common surgery was concomitant valve and
CABG; and aortic valve replacement was the most common
in those not requiring CABG. Bioprosthetic valve implanta-
tion was more commonly used in the dialysis patients. The
aortic cross-clamp and CPB times were both significantly
longer for the dialysis patients.In-Hospital Morbidity and Mortality
The unadjusted in-hospital outcomes are listed in Table 3.
In those patients undergoing dialysis preoperatively, in-
hospital morbidity was overwhelming increased compared
with those without preoperative dialysis. Furthermore, re-
source use as indicated by the time on a ventilator and theThe Journal of Thoracic and Caintensive care unit and overall postoperative length of stay
was significantly greater for those with preoperative dialy-
sis. The in-hospital mortality rate for the entire cohort
was 5.7% (n ¼ 304). Mortality was significantly greater
for those with preoperative dialysis (18.3% vs 5.2%;
P < .0001). The observed STS Predicted Risk of In-
hospital Mortality expected ratio was 1.27 for those without
preoperative dialysis compared with 1.24 for thosewith pre-
operative dialysis. Among the major cardiac adverse events,
only in-hospital death was statistically greater for the dial-
ysis patients (Table 4). However, on multivariate logistic re-
gression analysis (Table 5), chronic preoperative dialysis
showed a trend toward, but was not an independent predic-
tor for, in-hospital mortality (odds ratio, 1.51; 95% CI, 0.96
to 2.39; P ¼ .08). Other covariates included advanced age,
female gender, nondialysis renal failure, coronary artery
disease requiring CABG, and endocarditis.Long-Term Mortality
The median follow-up for all patients was 4.4 years.
The survival estimates for each group are listed in Table
6 and revealed that those patients undergoing preoperative
dialysis had significantly reduced all-cause mid- and long-
term survival. Graphically, this is represented in the
Kaplan-Meier curves (Figures 1 to 5). In an all patient
subgroup analysis, the patients with preoperative dialysisrdiovascular Surgery c Volume 144, Number 1 119
TABLE 3. Unadjusted short-term postoperative outcomes by dialysis
status
Outcome
No preoperative
dialysis
(n ¼ 5084)
Preoperative
dialysis
(n ¼ 224) P value
Myocardial infarction 24 (0.5) 3 (1.3) .074
Stroke 151 (3.0) 14 (6.3) .006
Mediastinitis 39 (0.8) 8 (3.6) <.001
Renal failure 363 (7.1) –– ––
Dialysis 140 (2.8) –– ––
Septicemia 147 (2.9) 26 (11.6) <.001
Heart block requiring
pacemaker
164 (3.2) 10 (4.7) .31
MSOF 86 (1.7) 16 (7.1) <.001
Re-exploration for
hemorrhage
300 (5.9) 19 (8.5) .11
Postoperative pneumonia 324 (6.4) 34 (15.2) <.001
Postoperative ventilator (h) <.001
Mean  SD 43  127 122  218
Median 9.1 33.2
Prolonged ventilation 744 (14.6) 106 (47.3) <.001
Postoperative IABP insertion 38 (0.8) 1 (0.5) .61
Gastrointestinal complication 219 (4.3) 32 (14.3) <.001
Total initial ICU LOS (h) <.001
Mean  SD 103  173 247  304
Median 46 121
Postoperative LOS (d) <.001
Mean  SD 9.1  9.0 17.4  16.6
Median 6.0 11.0
In-hospital mortality 263 (5.2) 41 (18.3) <.001
STS PROM (%) <.001
Mean  SD 4.1  4.2 14.8  9.2
Median 2.8 13.0
O/E mortality 1.27 1.24 ––
Data presented as numbers (%), unless otherwise noted. MSOF, Multisystem organ
failure; IABP, Intra-aortic balloon counterpulsation; ICU, Intensive care unit; LOS,
Length of stay; STS, Society of Thoracic Surgeons; PROM, Predicted risk of mortal-
ity; O/E, observed to expected.
TABLE 5. Significant preoperative predictors of in-hospital survival
from multivariate survival analysis
Preoperative variable Odds ratio (95% CI) P value
Age 1.03 (1.02–1.04) <.001
Chronic lung disease 0.99 (0.73–1.34) .94
CVA 1.31 (0.95–1.81) .10
EF 1.00 (0.988–1.004) .32
Infectious endocarditis 1.62 (1.11–2.35) .012
Female gender 1.59 (1.30–1.95) <.001
Heart failure 0.91 (0.74–1.13) .40
Renal failure 2.62 (1.90–3.62) <.001
Renal failure requiring dialysis 1.51 (0.96–2.39) .08
CAD requiring CABG 1.47 (1.18–1.82) <.001
Body mass index 1.01 (0.993–1.024) .29
Diabetes 1.04 (0.82–1.33) .74
CI, Confidence interval; CVA, Cerebrovascular accident; EF, Ejection fraction; CAD,
Coronary artery disease; CABG, Coronary artery bypass grafting.
Acquired Cardiovascular Disease Thourani et al
A
C
Dhad reduced survival. In the unadjusted survival analysis
for long-term mortality (Table 7), the instantaneous hazard
for death was 4.67 times greater if the patient required pre-
operative dialysis. After an age adjustment was performed,
it was shown that younger patients requiring preoperative
dialysis had worse survival (hazard ratio, 6.54; 95% CI,
5.41 to 7.89). When a full adjustment was performed using
11 covariates, preoperative chronic dialysis was stillTABLE 4. Adjusted odds ratios for in-hospital outcomes
Complications
No preoperative
dialysis (n ¼ 5084)
Preoperative
dialysis (n ¼ 2
In-hospital mortality 263 (5.2) 41 (18.3)
Stroke 151 (3.0) 14 (6.3)
Myocardial infarction 24 (0.47) 3 (1.34)
MACCE 394 (7.8) 48 (21.4)
Data presented as numbers (%), unless otherwise noted. CI, Confidence interval; MACCE
120 The Journal of Thoracic and Cardiovascular Surgassociated with reduced long-term survival (hazard ratio,
2.34; 95% CI, 1.83 to 2.99). Other independent covariates
for long-term survival (Table 8) included age, female gen-
der, nondialysis renal failure, heart failure, lower ejection
fraction, coronary artery disease requiring CABG, endo-
carditis, preoperative stroke, diabetes, and chronic lung
disease.
DISCUSSION
It has been estimated that approximately 50% of deaths in
patients with ESRD occurs from cardiovascular disease.4
Although it has been appreciated that the 2-year survival
rate in the dialysis population after a diagnosis of peripheral
vascular disease is approximately 40%, after cerebrovascu-
lar accident is 30%, after congestive heart failure is 42%,
and after coronary revascularization is 45%, the outcomes
after cardiac valve surgery have not been so clearly defined.4
Most published series regarding cardiac surgical procedures
for patients with dialysis-dependent ESRD have included
a heterogenous population of patients undergoing isolated
CABG, isolated valve surgery, or valve surgery with con-
comitant CABG.7,8,10,12-14,16,17 The present series differs
in that we did not include any patients undergoing isolated
CABG; because all patients underwent at least one valve
surgery. In the present series, concomitant CABG was
noted in 33% of the patients without preoperative dialysis
compared with 29% with dialysis. In concordance with24)
Unadjusted
P value
Adjusted odds
ratios (95% CI)
Adjusted
P value
<.001 1.80 (1.09–2.97) .021
.006 1.11 (0.53–2.31) .79
.074 1.47 (0.23–9.35) .68
<.001 1.52 (0.96–2.40) .07
, Major adverse cardiac and cerebrovascular events.
ery c July 2012
TABLE 6. Survival estimates by dialysis status
Variable No preoperative dialysis (n ¼ 5084) Preoperative dialysis (n ¼ 224)
Median survival (y) 12þ 1.78
1-Year survival (SE), number left at risk 89.5% (0.4%), n ¼ 3985* 59.2% (3.4%), n ¼ 105
3-Year survival (SE), number left at risk 84.4% (0.5%), n ¼ 2887* 42.3% (3.7%), n ¼ 48
5-Year survival (SE), number left at risk 78.4% (0.7%), n ¼ 1949* 28.9% (4.1%), n ¼ 18
10-Year survival (SE), number left at risk 63.9% (1.1%), n ¼ 530* 19.6% (4.9%), n ¼ 1
SE, Standard error. *P<.001.
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comorbid characteristics in those patients with dialysis-
dependent renal failure. It is without doubt that the increased
incidence of these variables lead to increased in-hospital
morbidity and mortality.7,8,10,12-14,16,17
In a retrospective review of 245 dialysis-dependent pa-
tients undergoing cardiac surgery at a single institution
during an 8-year period, Rahmanian and colleagues16
have shown that patients with ESRD had an in-hospital
mortality rate that was 3.7 times greater than that of non-
dialysis patients (12.7% vs 3.9%). An examination by
surgery type found that the mortality rate for isolated/mul-
tiple valve procedures was 17.1% compared with 12.8%
and 10.3% for valve/CABG and isolated CABG, respec-
tively. Unlike the report by Rahmanian and colleagues,16
the present series only included patients undergoing at
least one valvular operation. We demonstrated a similarly
dramatic increase in the morbidity and mortality for valve
procedures, with an in-hospital mortality rate for the dial-
ysis group of 18.3% compared with a rate of 5.2% for the
nondialysis group. Similarly, a multicenter retrospective
review from Germany identified 522 patients with ESRD
undergoing a variety of cardiac surgical procedures; in-
cluding 192 (36.8%) with valve plus concomitant
CABG.12 The patients in the ESRD group had a 30-day
mortality rate of 11.5% and an overall survival rate at 5
years of 41.5%, with the patients with isolated CABGFIGURE 1. Kaplan-Meier survival estimates for all patients by preopera-
tive dialysis status (P<.001 comparing groups).
The Journal of Thoracic and Cademonstrating improved survival compared with those re-
ceiving valve plus concomitant CABG. Despite the im-
provements in the perioperative treatment of patients
undergoing valve surgery, those patients requiring dialysis
for ESRD continue to have a three- to fourfold increase in
in-hospital mortality.
It has been noted that the average survival rate of patients
from the time of dialysis was started was 52% at 3 years and
33% at 5 years.18 This aspect is critically important as we
evaluate the mid- and long-term mortality in patients with
dialysis-dependent chronic renal failure undergoing cardiac
surgery.12,14,16,17 Although it is difficult to ascertain the
survivability of a patients with ESRD who does not
undergo the required cardiac surgical procedure, in the
present series, we noted a 5-year overall survival rate of
29%. Rahmanian and colleagues16 noted an estimated
5-year survival rate of 39% in a series of 245 heterogenous
patients undergoing cardiac surgery. In a series of 192 pa-
tients, Bechtel and colleagues12 noted an overall survival
rate at 5 years of 41.5%, with patients undergoing isolated
CABG demonstrating improved survival compared with
those undergoing valve plus concomitant CABG. In that
study, they showed that the determinants of long-term mor-
tality included emergency surgery, diabetes mellitus, age at
surgery, and number of allogenic transfusions. Subsequent
renal transplantation, the presence of sinus rhythm, and
the use of the internal thoracic artery were associated withFIGURE 2. Kaplan-Meier survival estimates for isolated aortic valve re-
placement by preoperative dialysis status (P<.001 comparing groups).
rdiovascular Surgery c Volume 144, Number 1 121
FIGURE 3. Kaplan-Meier survival estimates for isolatedmitral valve pro-
cedures by preoperative dialysis status (P<.001 comparing groups).
FIGURE 5. Kaplan-Meier survival estimates for any valve with concom-
itant coronary artery bypass grafting (CABG) by pre-operative dialysis sta-
tus (P<.001 comparing groups).
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leagues14 showed an actuarial survival rate at 1 and 5 years
of 59% and 21% for isolated aortic valve replacement and
44% and 33% for those undergoing other valve plus CABG
procedures, respectively.
Perioperative stroke is a primary concern in these pa-
tients. Dialysis-dependent patients are known to have
a more severe atherosclerotic disease burden than patients
without ESRD. In the general ESRD population, a new
stroke is an extraordinarily ominous occurrence. Patients
with ESRD aged 75 to 84 years have a 1-year mortality
rate of 20%. A new stroke in that same age group is associ-
ated with increase in the annual mortality rate to 60%.1 In
the present series, the unadjusted stroke rates were 6% in
dialysis patients compared with 3% in nondialysis patients
(P ¼ .006). Once adjusted, we found no significant differ-
ence in the postoperative stroke risk between the two groups
(P ¼ .79; Table 4). Similarly, Rahmanian and colleagues16
did not show an association between ESRD andFIGURE 4. Kaplan-Meier survival estimates for multivalve procedures
by preoperative dialysis status (P<.001 comparing groups).
122 The Journal of Thoracic and Cardiovascular Surgpostoperative stroke (3.3% in patients with ESRD vs
2.5% without ESRD). However, the patient populations
were quite varied between the two studies, because 40%
of their series included patients with isolated CABG, who
have a lower risk of postoperative stroke risk compared
with patients undergoing valve and concomitant CABG in
the present series. Although we were unable to predict the
stroke risk according to the aortic disease burden in the
present data set, this, along with the inherent increased
globalized small- and large-vascular atherosclerosis might
be a plausible explanation for the increased stroke rate in
this high-risk patient population.Study Limitations
The present study was limited by its observational nature
and the inherent limitations of a retrospective database
study. Although we controlled for confounding variables
using logistic regression analysis, it is likely that all factors
influencing selection bias were not accounted for in the
present analysis. Furthermore, the heterogeneity of the
study population could make it difficult to draw broad con-
clusions from these data. Although survival with dialysis
has improved during the past 20 years, it seems that most
of the gains have occurred within the first few years of treat-
ment. In the present study, we are unable to quantify how
long before admission, the patient’s dialysis had been initi-
ated. It is intuitive to believe that those patients who were
receiving dialysis for years versus months would have hadTABLE 7. Adjusted survival estimates for long-term survival
Estimate HR (95% CI) P value
Crude estimate (no adjustment) 4.67 (3.88–5.62) <.001
Age-adjusted estimate 6.54 (5.41–7.89) <.001
Full adjustment 2.34 (1.83–2.99) <.001
HR, Hazard ratio; CI, Confidence interval.
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TABLE 8. Significant preoperative predictors of long-term survival
from multivariate survival analysis
Preoperative variable HR (95% CI) P value
Age 1.04 (1.032–1.043) <.001
Chronic lung disease 1.28 (1.07–1.53) .006
CVA 1.54 (1.30–1.82) <.001
EF 0.99 (0.988–0.997) <.001
Infectious endocarditis 1.43 (1.16–1.78) <.001
Female gender 1.28 (1.14–1.43) <.001
Heart failure 1.25 (1.11–1.41) <.001
Renal failure 2.33 (1.96–2.78) <.001
Renal failure requiring dialysis 2.34 (1.83–2.99) <.001
CAD requiring CABG 1.34 (1.19–1.51) <.001
Body mass index 1.00 (0.99–1.01) .94
Diabetes 1.23 (1.08–1.41) .002
HR, Hazard ratio; CI, Confidence interval; CVA, Cerebrovascular accident; EF, Ejec-
tion fraction; CAD, Coronary artery disease; CABG, Coronary artery bypass grafting.
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of our group. Finally, important operative variables were not
available, such as the echocardiographic parameters. Al-
though biologic versus mechanical valves were not evalu-
ated in our study, Thourani and colleagues19 have noted
similar mid- and long-term survival between valve types.
CONCLUSIONS
The present study represents one of the largest series to
date to evaluate the outcomes of patients with ESRD after
cardiac valve surgery. Although limited by its retrospective
design, it illustrates the short-term morbidity and long-term
mortality for this difficult patient cohort. Careful preopera-
tive risk assessment and resource use should precede valve
surgery in patients undergoing preoperative chronic dialysis
for ESRD. Additional research investigation in the reduc-
tion of the high morbidity and mortality in patients with
ESRD is warranted.
The authors from Emory University express their gratitude to
staff members Kim Baio for project oversight, to Jean Walker
and Susan Joyce for data abstraction, and to Deborah Canup for da-
tabase management.
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